Rothschild lands second Spanish drugs role

Rothschild has worked on its second mandate from Almirall in less than a month after it advised the Spanish pharmaceutical company on its acquisition of a German rival.

The UK bank advised Almirall on its £255m (€378m) purchase of German pharma company Hermal weeks after its joint equity underwriting venture with ABN Amro acted as financial adviser for the Spanish company's €698m ($937m) Madrid stock market flotation.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump